Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

ENFLONSIA™ (clesrovimab) shows positive new results in infants and children under 2 at increased risk of severe RSV disease across two seasons, Merck reports

and an investigator for the SMART clinical trial. “These new findings from SMART demonstrate the potential of ENFLONSIA to help protect these vulnerable children, who may require an additional dose for their second RSV season.” Interim data from...

To strengthen global AI, data strategy, evidence synthesis, and economic modelling capabilities, Precision AQ expands its senior leadership team

expands and global regulatory expectations evolve. Emma's depth of experience in evidence and modelling will be pivotal in helping our clients navigate these pressures and strengthen their market access strategy," said Jake Graetz, Chief Business...

A Breakthrough Study Confirms HYD LLC's 30-Year Research on Deuterium Modulation in Cancer Gene Expression.

our long-held hypothesis that deuterium depletion can exert anticancer effects at the sub-molecular level." These findings help explain earlier results, where data from 2,649 cancer patients who drank DDW showed that adding DDW to regular...

China approves Libevitug, first-in-class therapy for hepatitis D

rates for viral hepatitis and reduce the incidence of liver cancer and mortality. We anticipate that Libevitug will help effectively lower the risk of disease progression to advanced severe diseases such as liver cancer, drive the standardization...

HanchorBio Partners with WuXi Biologics to Advance Next-Generation Fusion Protein Pipeline

commitment to quality, we strive to accelerate the development of HanchorBio's innovative bi-/multi fusion proteins and help bring transformative therapies to patients worldwide. About HanchorBio Based in Taipei, Shanghai, and the San Francisco Bay...

BIOCORNEUM® announces the availability of its new dual-action bruise system designed to enhance post-procedure recovery

announced the immediate availability of its new Bruise Care System. The innovative dual-approach regimen is designed to help patients prepare for and recover more quickly from cosmetic and surgical procedures, including injections, dermal fillers,...

First National Campaign Launched by Trauma Intervention Programs (TIP)

TIP to elevate that mission nationally, and the leadership of board members like Maryam Parman has been instrumental in helping TIP reach this moment. "Our services are unique because we focus on the immediate emotional aftermath—helping survivors...

Lansinoh® Launched NaturalWave® Double Electric Breast Pump Featuring Exclusive Flutter Technology for Increased Milk Output

the NaturalWave® Double Electric Breast Pump, a next-generation power pump engineered to solve a major gap in the market: helping moms not just express milk, but effectively boost and maintain their supply through innovative technology and built-in...

Align Technology Supports Children and Teens With 30 Invisalign® Treatments via Smiles4Canada Program

does not have the financial resources to pay for the procedure. “Align’s support of Smiles4Canada is critical, as it helps orthodontists provide care to young patients who need it most,” said Alison Nash, Executive Director, CFAO. “Their commitment...

Ad Hoc Analyses Indicate Enhanced Survival Outcomes with VYLOY™ (zolbetuximab) Combined with Chemotherapy When Common Adverse Events Are Properly Managed

such as nausea and vomiting observed during the first infusion. The authors noted that infusion-rate modifications may help mitigate these symptoms.1 Exploratory ad hoc analyses are hypothesis generating, and further work investigating the clinical...

PureWay and PPSWG Form New Partnership to Transform Pharmaceutical Waste Management in the U.S.

to safeguarding public health through education and responsible disposal of medicines and sharps. This effort will help to protect and educate communities while setting a new standard for responsible and sustainable pharmaceutical waste management...

FDA Approves New 2-Gram Fibryga® Presentation to Improve Convenience and Precision in Treating Acquired Fibrinogen Deficiency

said Flemming Nielsen, President, Octapharma USA. "By simplifying preparation and expanding dosing flexibility, we're helping providers act faster and more precisely – when every second counts." Fibryga® is the first and only virus-inactivated,...

Ark Biopharmaceutical Granted China Marketing Authorization for Aizhida in ADHD Treatment

The approval of Aizhida provides clinicians with a new therapeutic tool. We anticipate its real-world application will help improve the treatment landscape for ADHD patients in China, offering new hope particularly for those with suboptimal...

Novotech Appoints Anand Tharmaratnam as Chief Executive Officer

global and complex biotech programs. Novotech will continue to deliver impactful and innovative outcomes for clients to help advance future medicines.” About Novotech Novotech is a globally recognized full-service clinical research organization...

Sapio Sciences Collaborates with the Wellcome Sanger Institute on Transforming Digital Laboratories

continue shaping the future of genomic science,” said Mike Hampton, Chief Commercial Officer at Sapio Sciences. “Sanger helped set the standard for large-scale genomics, and they have very clear expectations for their scientific enablement. With...

GMA with MOVIVA®: Setting New Standards in Endoscopic Bariatric Treatment.

expanding across Europe. With around 80 procedures performed within a short timeframe in eight countries, MOVIVA® is helping to establish a new era of endoscopic bariatric treatment – offering a less invasive option as obesity rates continue to...

Menarini Group Shares New Data on ELZONRIS® (tagraxofusp-erzs)

important role in both monotherapy and combination settings for the treatment of BPDCN, and that it also has potential to help patients living with other aggressive hematologic malignancies, where more effective treatment options are desperately...

VahatiCor Closes Oversubscribed Series B Financing to Speed Up A-FLUX® Development for Coronary Microvascular Dysfunction

(CMD), a condition that can cause chest pressure, heaviness, and discomfort. Through this advancement, VahatiCor is helping broaden access to care for individuals who have long faced limited treatment alternatives. About S3 Ventures Founded in...

Emulate, in Partnership with FUJIFILM Cellular Dynamics, Launches Brain-Chip R1 to Advance Neurological Drug Development

cells including Emulate’s proprietary BMECs, and Brain-Chip media. This integrated offering simplifies implementation, helping researchers rapidly advance their CNS studies with enhanced human relevance. The Brain-Chip R1 is compatible with...

Jazz Pharmaceuticals presents new clinical and translational data for Modeyso™ (dordaviprone) in H3 K27M-mutant diffuse midline glioma at SNO 2025

molecular pathways associated with sensitivity to dordaviprone and exploring how targeted combination strategies may help to enhance response. \Preclinical data evaluating how dordaviprone may influence the tumor immune environment to inform future...